English  |  正體中文  |  简体中文  |  總筆數 :2827024  
造訪人次 :  32010474    線上人數 :  894
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"pei jer chen"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 561-585 / 883 (共36頁)
<< < 18 19 20 21 22 23 24 25 26 27 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-07-03T03:33:58Z Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:57Z Linifanib versus sorafenib in patients with advanced hepatocellular carcinoma: Results of a randomized phase III trial Cainap C.; Qin S.; Huang W.-T.; Chung I.J.; Pan H.; Cheng Y.; Kudo M.; Kang Y.-K.; PEI-JER CHEN; Toh H.-C.; Gorbunova V.; Eskens F.A.L.M.; Qian J.; McKee M.D.; Ricker J.L.; Carlson D.M.; El-Nowiem S.
臺大學術典藏 2021-07-03T03:33:57Z Sorafenib Action in Hepatitis B Virus X-Activated Oncogenic Androgen Pathway in Liver Through SHP-1 Wang S.-H.; Yeh S.-H.; Shiau C.-W.; Chen K.-F.; Lin W.-H.; Tsai T.-F.; Teng Y.-C.; Chen D.-S.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:57Z Use of HLA-B?58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: National prospective cohort study Ko T.-M.; Tsai C.-Y.; Chen S.-Y.; Chen K.-S.; Yu K.-H.; Chu C.-S.; Huang C.-M.; Wang C.-R.; Weng C.-T.; Yu C.-L.; Hsieh S.-C.; Tsai J.-C.; Lai W.-T.; Tsai W.-C.; Yin G.-D.; Ou T.-T.; Cheng K.-H.; Yen J.-H.; Liou T.-L.; Lin T.-H.; Chen D.-Y.; Hsiao P.-J.; Weng M.-Y.; Chen Y.-M.; Chen C.-H.; Liu M.-F.; Yen H.-W.; Lee J.-J.; Kuo M.-C.; Wu C.-C.; Hung S.-Y.; Luo S.-F.; Yang Y.-H.; Chuang H.-P.; Chou Y.-C.; Liao H.-T.; Wang C.-W.; Huang C.-L.; Chang C.-S.; Lee M.-T.M.; PEI-JER CHEN; Wong C.-S.; Chen C.-H.; Wu J.-Y.; Chen Y.-T.; Shen C.-Y.
臺大學術典藏 2021-07-03T03:33:56Z Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏 2021-07-03T03:33:56Z Chronic Hepatitis B virus infection Yuen M.-F.;Ahn S.H.;Chen D.-S.;Pei-Jer Chen;Dusheiko G.M.;Hou J.-L.;Maddrey W.C.;Mizokami M.;Seto W.-K.;Zoulim F.;Lai C.-L.; Yuen M.-F.; Ahn S.H.; Chen D.-S.; PEI-JER CHEN; Dusheiko G.M.; Hou J.-L.; Maddrey W.C.; Mizokami M.; Seto W.-K.; Zoulim F.; Lai C.-L.
臺大學術典藏 2021-07-03T03:33:56Z Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; PEI-JER CHEN; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:55Z Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model Li Y.-T.;Liu C.-J.;Su T.-H.;Cheng H.-R.;Jeng Y.-M.;Lin H.-L.;Wang C.-C.;Kao J.-H.;Pei-Jer Chen;Chen D.-S.;Wu H.-L.; Li Y.-T.; Liu C.-J.; Su T.-H.; Cheng H.-R.; Jeng Y.-M.; Lin H.-L.; Wang C.-C.; Kao J.-H.; PEI-JER CHEN; Chen D.-S.; Wu H.-L.
臺大學術典藏 2021-07-03T03:33:55Z Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update Sarin S.K.;Kumar M.;Lau G.K.;Abbas Z.;Chan H.L.Y.;Chen C.J.;Chen D.S.;Chen H.L.;Pei-Jer Chen;Chien R.N.;Dokmeci A.K.;Gane E.;Hou J.L.;Jafri W.;Jia J.;Kim J.H.;Lai C.L.;Lee H.C.;Lim S.G.;Liu C.J.;Locarnini S.;Al Mahtab M.;Mohamed R.;Omata M.;Park J.;Piratvisuth T.;Sharma B.C.;Sollano J.;Wang F.S.;Wei L.;Yuen M.F.;Zheng S.S.;Kao J.H.; Sarin S.K.; Kumar M.; Lau G.K.; Abbas Z.; Chan H.L.Y.; Chen C.J.; Chen D.S.; Chen H.L.; PEI-JER CHEN; Chien R.N.; Dokmeci A.K.; Gane E.; Hou J.L.; Jafri W.; Jia J.; Kim J.H.; Lai C.L.; Lee H.C.; Lim S.G.; Liu C.J.; Locarnini S.; Al Mahtab M.; Mohamed R.; Omata M.; Park J.; Piratvisuth T.; Sharma B.C.; Sollano J.; Wang F.S.; Wei L.; Yuen M.F.; Zheng S.S.; Kao J.H.
臺大學術典藏 2021-07-03T03:33:54Z Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study Su T.-H.;Liu C.-J.;Tseng T.-C.;Chou S.-W.;Liu C.-H.;Yang H.-C.;Wu S.-J.;Pei-Jer Chen;Chen D.-S.;Chen C.-L.;Kao J.-H.; Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:54Z Hepatocellular carcinoma and hepatitis C virus Wang S.-H.;Yeh S.-H.;Pei-Jer Chen; Wang S.-H.; Yeh S.-H.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:53Z Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen Zhang T.-Y.;Yuan Q.;Zhao J.-H.;Zhang Y.-L.;Yuan L.-Z.;Lan Y.;Lo Y.-C.;Sun C.-P.;Wu C.-R.;Zhang J.-F.;Zhang Y.;Cao J.-L.;Guo X.-R.;Liu X.;Mo X.-B.;Luo W.-X.;Cheng T.;Chen Y.-X.;Tao M.-H.;Shih J.W.K.;Zhao Q.-J.;Zhang J.;Pei-Jer Chen;Yuan Y.A.;Xia N.-S.; Zhang T.-Y.; Yuan Q.; Zhao J.-H.; Zhang Y.-L.; Yuan L.-Z.; Lan Y.; Lo Y.-C.; Sun C.-P.; Wu C.-R.; Zhang J.-F.; Zhang Y.; Cao J.-L.; Guo X.-R.; Liu X.; Mo X.-B.; Luo W.-X.; Cheng T.; Chen Y.-X.; Tao M.-H.; Shih J.W.K.; Zhao Q.-J.; Zhang J.; PEI-JER CHEN; Yuan Y.A.; Xia N.-S.
臺大學術典藏 2021-07-03T03:33:53Z Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studies Grotzinger K.M.;Younossi Z.M.;Giannini E.G.;Pei-Jer Chen;Rendas-Baum R.;Theodore D.; Grotzinger K.M.; Younossi Z.M.; Giannini E.G.; PEI-JER CHEN; Rendas-Baum R.; Theodore D.
臺大學術典藏 2021-07-03T03:33:53Z Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection Yang W.-T.;Wu L.-W.;Tseng T.-C.;Chen C.-L.;Yang H.-C.;Su T.-H.;Wang C.-C.;Kuo S.F.-T.;Liu C.-H.;Pei-Jer Chen;Chen D.-S.;Liu C.-J.;Kao J.-H.; Yang W.-T.; Wu L.-W.; Tseng T.-C.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:52Z Perspectives on dual hepatitis B and C infection in Taiwan Liu C.-J.;Pei-Jer Chen;Chen D.-S.;Tseng T.-C.;Kao J.-H.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Tseng T.-C.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:52Z Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B) Chan H.L.Y.;Ahn S.H.;Chang T.-T.;Peng C.-Y.;Wong D.;Coffin C.S.;Lim S.G.;Pei-Jer Chen;Janssen H.L.A.;Marcellin P.;Serfaty L.;Zeuzem S.;Cohen D.;Critelli L.;Xu D.;Wind-Rotolo M.;Cooney E.;Lira-B Study Team; Chan H.L.Y.; Ahn S.H.; Chang T.-T.; Peng C.-Y.; Wong D.; Coffin C.S.; Lim S.G.; PEI-JER CHEN; Janssen H.L.A.; Marcellin P.; Serfaty L.; Zeuzem S.; Cohen D.; Critelli L.; Xu D.; Wind-Rotolo M.; Cooney E.; LIRA-B Study Team
臺大學術典藏 2021-07-03T03:33:52Z The Hepatitis Viral Status in Patients with Hepatocellular Carcinoma: A Study of 3843 Patients from Taiwan Liver Cancer Network Chang I.-C.;Huang S.-F.;Pei-Jer Chen;Chen C.-L.;Chen C.-L.;Wu C.-C.;Tsai C.-C.;Lee P.-H.;Chen M.-F.;Lee C.-M.;Yu H.-C.;Lo G.-H.;Yeh C.-T.;Hong C.-C.;Eng H.-L.;Wang J.;Tseng H.-H.;Hsiao C.-H.;Wu H.-D.I.;Yen T.-C.;Liaw Y.-F.; Chang I.-C.; Huang S.-F.; PEI-JER CHEN; Chen C.-L.; Chen C.-L.; Wu C.-C.; Tsai C.-C.; Lee P.-H.; Chen M.-F.; Lee C.-M.; Yu H.-C.; Lo G.-H.; Yeh C.-T.; Hong C.-C.; Eng H.-L.; Wang J.; Tseng H.-H.; Hsiao C.-H.; Wu H.-D.I.; Yen T.-C.; Liaw Y.-F.
臺大學術典藏 2021-07-03T03:33:51Z Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice Lin W.-H.;Yeh S.-H.;Yeh K.-H.;Chen K.-W.;Cheng Y.-W.;Su T.-H.;Jao P.;Ni L.-C.;Pei-Jer Chen;Chen D.-S.; Lin W.-H.; Yeh S.-H.; Yeh K.-H.; Chen K.-W.; Cheng Y.-W.; Su T.-H.; Jao P.; Ni L.-C.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:33:51Z Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma Sung F.-Y.;Lan C.-Y.;Huang C.-J.;Lin C.-L.;Liu C.-J.;Pei-Jer Chen;Lin S.-M.;Yu M.-W.; Sung F.-Y.; Lan C.-Y.; Huang C.-J.; Lin C.-L.; Liu C.-J.; PEI-JER CHEN; Lin S.-M.; Yu M.-W.
臺大學術典藏 2021-07-03T03:33:51Z Liver gene expression profiles correlate with virus infection and response to interferon therapy in chronic hepatitis B patients Wu H.-L.;Hsiao T.-H.;Pei-Jer Chen;Wong S.-H.;Kao J.-H.;Chen D.-S.;Lu J.-Y.;Lu T.-P.;Chen Y.;Chuang E.Y.;Tu H.-C.;Liu C.-J.; Wu H.-L.; Hsiao T.-H.; PEI-JER CHEN; Wong S.-H.; Kao J.-H.; Chen D.-S.; Lu J.-Y.; Lu T.-P.; Chen Y.; Chuang E.Y.; Tu H.-C.; Liu C.-J.
臺大學術典藏 2021-07-03T03:33:50Z A novel toolbox for the in vitro assay of hepatitis D virus infection Zhao J.-H.; Zhang Y.-L.; Zhang T.-Y.; Yuan L.-Z.; Cheng T.; PEI-JER CHEN; Yuan Q.; Xia N.-S.
臺大學術典藏 2021-07-03T03:33:50Z Management of hepatitis C virus infection in the Asia-Pacific region: an update Lim S.G.; Aghemo A.; PEI-JER CHEN; Dan Y.Y.; Gane E.; Gani R.; Gish R.G.; Guan R.; Jia J.D.; Lim K.; Piratvisuth T.; Shah S.; Shiffman M.L.; Tacke F.; Tan S.S.; Tanwandee T.; Win K.M.; Yurdaydin C.
臺大學術典藏 2021-07-03T03:33:50Z Hydrodynamic HBV transfection mouse model Wu L.-L.; Wang H.-Y.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:50Z Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C Mah Y.-H.;Liu C.-H.;Chen C.-L.;Tseng T.-C.;Liu C.-J.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Mah Y.-H.; Liu C.-H.; Chen C.-L.; Tseng T.-C.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:49Z One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature Chen Y.-J.; Dela Rosa M.A.C.; Chen W.-C.; Chen Y.-J.; Obena R.P.; Chang C.-H.; Capangpangan R.Y.; Su T.-H.; Chen C.-L.; PEI-JER CHEN

顯示項目 561-585 / 883 (共36頁)
<< < 18 19 20 21 22 23 24 25 26 27 > >>
每頁顯示[10|25|50]項目